A Double Blind, Randomised, Placebo-controlled, Multiple Ascending-dose Study to Assess the Pharmacokinetics, Pharmacodynamics, Safety and Tolerability of DS 1093a in Healthy Male Subjects

Trial Profile

A Double Blind, Randomised, Placebo-controlled, Multiple Ascending-dose Study to Assess the Pharmacokinetics, Pharmacodynamics, Safety and Tolerability of DS 1093a in Healthy Male Subjects

Completed
Phase of Trial: Phase I

Latest Information Update: 14 Aug 2017

At a glance

  • Drugs DS 1093 (Primary)
  • Indications Anaemia
  • Focus Adverse reactions; Pharmacokinetics
  • Sponsors Daiichi Sankyo Inc
  • Most Recent Events

    • 13 Apr 2015 Status changed from recruiting to completed as reported by ClinicalTrials.gov record.
    • 18 Nov 2014 Status changed from not yet recruiting to recruiting as reported by ClinicalTrials.gov.
    • 26 May 2014 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top